Cytosolic hybrid histidine kinases (HHKs) constitute major signalling nodes that control various biological processes, but their input signals and how these are processed are largely unknown. In Caulobacter crescentus, the HHK ShkA is essential for accurate timing of the G1-S cell cycle transition and is regulated by the corresponding increase in the level of the second messenger c-di-GMP. Here, we use a combination of X-ray crystallography, NMR spectroscopy, functional analyses and kinetic modelling to reveal the regulatory mechanism of ShkA. In the absence of c-di-GMP, ShkA predominantly adopts a compact domain arrangement that is catalytically inactive. C-di-GMP binds to the dedicated pseudo-receiver domain Rec1 thereby liberating the canonical Rec2 domain from its central position where it obstructs the large-scale motions required for catalysis. Thus, c-di-GMP cannot only stabilize domain interactions, but also engage in domain dissociation to allosterically control activity. Enzyme kinetics data are consistent with conformational selection of the ensemble of active domain constellations by the ligand.
GMP mediated cross-linking of the DHp and CA domain was identified as the molecular mechanism of the switch 13 . Most recently it was found that ShkA, the other major kinase involved in the regulation of the C. crescentus cell cycle progression and morphogenesis 14 , is also controlled by c-di-GMP 9 . However, in contrast to CckA, which upon binding of c-di-GMP switches into phosphatase mode, the ligand is required for ShkA kinase activity suggesting a distinct mechanism of allosteric control.
Here, we reveal the molecular mechanism of ShkA regulation, which is based on c-di-GMP mediated mobilization of a locked, auto-inhibited domain arrangement. We have determined crystal structures of full-length ShkA and of its isolated Rec1 domain in complex with c-di-GMP and have analyzed the dynamics of the full-length enzyme by NMR spectroscopy employing isoleucine methyl group isotope labelling. Comprehensive enzymatic analyses revealed the underlying thermodynamics of the regulatory mechanism. Finally, a general model for the structural transitions during the catalytic cycle of HHKs is proposed. 7 by identifying unambiguous NOEs in agreement with the crystal structure. Additional assignments for isoleucine methyl groups δ1-I340, δ1-I390 and δ1-I405 were obtained using selective mutagenesis of full-length ShkA (Supplemental Fig. 2c ). The mutation I259V located within the Rec1 domain caused major spectral changes, indicating the importance of residue I259 in stabilizing the Rec1-CA domain interface (Supplemental Fig. 1b ).
AMPPNP binding to the CA domain of full-length ShkA leads to only minimal chemical shift perturbation of the δ1-Ile methyl groups of the entire protein, implying that the structures of ligandfree and AMPPNP-bound ShkA are very similar ( Fig. 2e and Supplemental Fig. 2b ). In contrast, binding of c-di-GMP to either apo ShkA or to ShkA/AMPPNP causes substantial spectral changes. Overall, these data indicate that c-di-GMP binding to ShkA leads to liberation of the Rec2 domain from the protein core. To validate this hypothesis, we conducted NMR spin relaxation experiments in the presence and absence of c-di-GMP ( Fig. 2f and Supplemental Fig. 2f ). For the isolated receiver domains, average 13 C transverse relaxation times for ILV methyl groups of Rec2 and Rec1 are quite similar (174 ms and 160 ms, respectively), in agreement with the similar molecular weight of both domains (16.3 kDa and 12.5 kDa, respectively). For full-length ShkA/AMPPNP in the absence of cdi-GMP, the transverse relaxation times of all δ1-Ile resonances is smaller (25 -75 ms), as expected from the respective protein sizes (Fig. 2f ). Addition of c-di-GMP strongly increases the 13 C T2 times of Rec2 such that 13 C T2 times are effectively doubled, but does not significantly affect those of δ1-Ile of Rec1 ( Fig. 2f and Supplemental Fig. 2f ). These experiments thus quantitatively confirm that c-di-GMP binding to ShkA leads to the specific detachment of the Rec2 domain from the protein core into a dynamic, multi-conformational state, which enables the enzyme to undergo the large motions required for the phosphoryl transfer reactions.
C-di-GMP competes with Rec1-Rec2 linker for binding to Rec1 domain
To reveal the molecular mechanism of c-di-GMP-induced Rec2 domain mobilization, we set out to determine the structure of the ShkA/c-di-GMP complex. Well-diffracting crystals were obtained for the isolated Rec1 domain, but not for full-length ShkA/c-di-GMP, and the structure was determined to Table 1 ). The asymmetric unit contains two monomers each with a bound monomeric c-di-GMP ligand, which are virtually identical and superimpose closely with the corresponding domain in full-length ShkA (Supplement Fig. 3b ). In addition, an intercalated c-di-GMP dimer is observed that mediates a 2-fold symmetry contact between the two Rec1 monomers that is most likely a crystal artefact. Indeed, the ITC data of full-length ShkA are consistent with 1:1 stoichiometry (Supplemental Fig. 4 ).
to the surface that is involved in the dimerization of canonical Rec domains. The Watson-Crick edges of both guanine bases form H-bonds with the backbone of the exposed edge of the β5 edge and the β5-α5 loop. In addition, Y338 and R344 are forming stacking and cation -π interactions with the guanyl bases, respectively. S347 is H-bonded to a guanyl base, and R324 forms an ionic interaction with a c-di-GMP phosphate. All interacting ShkA residues are highly conserved in related sequences ( Fig. 3c ).
In full-length ShkA, the c-di-GMP binding site is occupied by the Rec1-Rec2 linker (Figs. 1c, 3d).
Specifically, residues shown to be engaged in c-di-GMP binding (Y338, R324, and R344) are interacting with a conserved DDR motif of the linker region. Thus, we reasoned that if the DDR segment were to compete with c-di-GMP binding, its deletion should increase c-di-GMP affinity.
Indeed, affinity measurements by ITC and fluorescence competition showed that the DHp-CA-Rec1 construct had a lower dissociation constant compared to the other investigated variants ( Fig. 3e ). Why this difference is considerably more pronounced in the fluorescence data is not clear.
Taking together all data on structure and dynamics, we propose a "ligand-coupled conformational equilibrium" (LCCE) model as the mechanism underlying c-di-GMP mediated ShkA activation (Figs. 4a, b). In the absence of c-di-GMP, the enzyme is in a dynamic equilibrium between a closed, autoinhibited state (Ec) and an ensemble of open, inhibition-relieved states (Eo) that are characterized by a liberated Rec2 domain. In absence of the ligand, this equilibrium would be populated largely on the Ec side, in line with the NMR results and the constitutive inactivity of the enzyme. C-di-GMP mediated ShkA activation would then proceed by conformational selection 16 of the Eo states with their unobstructed Rec1 binding site, shifting the equilibrium in a dose-dependent fashion to the active states.
The regulatory model was tested in vivo by analyzing the activity of ShkA variants with a β-Gal transcription assay. While in absence of c-di-GMP (rcdG 0 strain), wt ShkA showed no transcriptional activity, introducing D369N or placing an insertion between the DDR motif and Rec2 (but not between Rec1 and DDR) rendered ShkA active ( Fig. 4c ). Thus, the results fully corroborate the regulatory model, as illustrated in the scheme (Fig. 4c, right) . Additional support for the model is 
ShkA auto-phosphorylation is c-di-GMP dependent, reversible and non-cooperative
To determine the reaction kinetics of the full-length ShkA and mutants thereof, we acquired progress curves of enzyme net phosphorylation (E*) by auto-radiography and of ATP to ADP turn-over by online ion exchange chromatography (oIEC, see Methods) quantification. First, we determined the kinetics of auto-phosphorylation separately using phosphotransfer deficient variants that had the phospho-acceptor D430 mutated (ShkAD/A) or the Rec2 domain deleted (ShkAΔRec2). As found previously 9, 14 and consistent with the proposed regulatory model, ShkAΔRec2 is constitutively active (Figs. 5a, b), since it lacks the obstructing Rec2 domain. ShkAΔRec2 attains very quickly (in less than 15 s) a stable phosphorylation state with or without the ligand. For ShkAD/A, the same fast kinetics is observed, but only in presence of c-di-GMP (Figs. 5c, d), which demonstrates that under this condition the mutant is fully active. In absence of the ligand, the reaction velocity is strongly reduced, but phosphorylation is obtained to almost the same degree as for the activated enzyme. The observations are consistent with the regulatory LCCE model ( Fig. 4 ) under the assumption that the kinetics of the conformational equilibration are fast compared to the chemical reaction. Since the initial reaction velocity is at least 10-times larger in the presence of c-di-GMP ( Fig. 5d ), a lower boundary of 10 can be estimated for the conformational equilibrium constant K := [Ec]/ [Eo] .
To obtain more quantitative information about the auto-phosphorylation reaction, we measured ATP to ADP turnover by oIEC. Figures 5b and d show the ADP progress curves (filled symbols) of the phosphotransfer deficient ShkA mutants that turn out to be closely congruent with the appropriately scaled phosphorylation curves (open symbols). This indicates stable histidine phosphorylation at the employed condition as verified by long-term measurements (Supplemental Fig. 6b ). Intriguingly, the progress curves (Figs. 5b, d) indicate that the phosphotransfer-deficient mutants do not proceed to full quantitative modification, i.e. did not reach the level corresponding to the enzyme concentration (10 μM). We reasoned that this may be due to reversibility of the auto-phosphorylation reaction, and that only a high ATP substrate concentration would shift the equilibrium completely to the product state. 
C-di-GMP shifts thermodynamic ShkA equilibrium to the active state
Full-length ShkA is an ATPase, converting ATP to ADP via phospho-enzyme intermediates ( Fig. 6a ).
Progress curves acquired at various ATP and ADP concentrations showed good agreement with a competitive product inhibition Michaelis-Menten model (Supplemental Fig. 7a , c). The derived Km and Ki parameters are both about 60 μM. These values agree reasonably well (within a factor of 2 to 3) with the ITC measurements (Supplemental Fig. 4 ). The derived effective rate constant keff = 0.21 s -1 is similar to the estimate of the auto-phosphorylation rate (0.43 s -1 ) that can be calculated from the ShkAD/A data acquired in absence of c-di-GMP ( Fig. 4d ) assuming a K=49 (see below).
To quantitatively describe the activating effect of c-di-GMP, progress curves were acquired at various c-di-GMP concentrations (Supplemental Fig. 7b ) and fitted with the Michaelis-Menten model. The This value is smaller than those obtained for the DHp-CA-Rec1 construct by fluorescence competition and ITC (80 nM, 300 nM; Fig. 3e ), which may be due to residual binding competition by the truncated Rec1-Rec2 linker.
In summary, the enzymatic characterization shows that, in the presence of c-di-GMP, ShkA efficiently catalyses auto-phosphorylation and subsequent phospho-transfer and dephosphorylation.
The data fully support the regulatory LCCE model and thus confirm that the c-di-GMP activation profile is governed not only by the affinity of the ligand to its binding site, but also by the free energy difference between the conformational states.
Structural modelling suggests a two-state catalytic cycle for hybrid histidine kinases
In a next step, we modelled the full catalytic cycle of ShkA based on the available structural and functional data and on general considerations of HHKs. Evidence has accumulated that the autophosphorylation competent form of HKs is an asymmetric dimer 6 . Recently, it has been proposed that such an asymmetric dimer can in fact catalyze both auto-phosphorylation and phosphoryl-transfer in concert and a structural model has been put forward for CpxA 17 . The corresponding ShkA model of an asymmetric dimer relieved from auto-inhibition is shown in Fig. 7a 
Discussion
The structural, dynamic, and functional results presented in this study consistently show that activation of ShkA proceeds via the c-di-GMP mediated liberation of a locked, auto-inhibited state ( Fig. 4) . Thereby, c-di-GMP competes with the tethering of a domain linker (Figs. 3a,d) to unleash the C-terminal domain allowing the enzyme to step through the catalytic cycle that involves large domain 13 motions ( Fig. 7 ). C-di-GMP interference with protein -protein interactions as a regulatory mechanism was also proposed for a YajQ-like transcription factor / co-activator complex 19 , but structural information is missing.
In ShkA, c-di-GMP binds to the edge strand (β5) of the Rec1 β-sheet and the following β5 -α5 loop.
The Watson-Crick edges of both guanines form H-bonds with the main-chain ( Fig. 3b ), reminiscent of the backbone interactions in a β-sheet. The same kind of interaction occurs in the CckA/c-di-GMP complex, where one of the guanines binds to the β-sheet edge of the CA domain 13 . In the accompanying study 9 , Y338 was identified as a c-di-GMP binding residue in a targeted alanine scan.
In addition to Y338A, several other mutants (R324A, I340A, S347A, and Q351A) showed severely impaired activity in vivo 9 . Since all these residues contribute to c-di-GMP binding (Fig. 3b ), this can be attributed to an impaired activation by the cellular c-di-GMP pool and suggests that the affinity of wild-type ShkA to c-di-GMP is finely tuned to its raise in concentration during cell cycle progression 20 .
A mutation of R344, the remaining c-di-GMP binding residue, showed a wild type-like phenotype. Although R324 also has such a dual role, its strong phenotype suggests that this residue contributes more to c-di-GMP binding than to linker tethering. These observations demonstrate that identification of ligand binding residues is not straightforward if they are also involved in opposing activities like protein -protein interactions. However, mutation of the DDR motif or inserting a loop between the motif and the Rec2 domain clearly resulted in constitutively active enzyme and, thus, confirmed the importance of Rec2 tethering for auto-inhibition (Fig. 4c ).
The NMR studies on full-length ShkA using specific isotope labelling of the isoleucine methyl groups provided atomic scale information of structural and dynamic changes upon ligand binding (Fig. 2) .
Binding of c-di-GMP, but not AMPPNP, changed the dynamics of Rec2 substantially and exclusively, leading to the conclusion that the mobility of the Rec2 domain is restricted in the absence of c-di-GMP but is drastically enhanced upon addition of the ligand such that its relaxation times become comparable to those of an individual protein of this size. The binding of c-di-GMP to Rec1 therefore releases Rec2 allosterically.
In order to relate the mechanistic "activation by domain liberation" model of ShkA with the function of this hybrid kinase, comprehensive enzymatic data were acquired. The newly developed oIEC method proved highly valuable as it enabled the efficient recording of quantitative enzyme progress curves. We found, using phospho-transfer deficient mutants, that ShkA auto-phosphorylation is clearly reversible. Under various titration regimes, the equilibrium concentrations were consistent with a simple reversible bi-bi reaction with the equilibrium largely on the side of the reactants ( HKs 23 and whether this feature is of physiological relevance. The rate constant of autophosphorylation is with k1 = 0.4 s -1 at least 20 times faster than measured for other HKs 13, 24 . Possibly, some of these enzymes were partly impaired by truncation and/or not fully activated. ATP turnover of full-length ShkA proceeds somewhat slower, which demonstrates that phospho-transfer and P~Asp hydrolysis are not much slower. To answer whether the latter reaction is entirely due to the intrinsic lability of the phospho-aspartate or catalysed by docking of the Rec2 domain to the DHp bundle 3, 15 requires further investigations.
It is generally believed that only one of the two symmetry related histidines of HKs can get phosphorylated at a given time, since the kinase state involves an asymmetric dimer. Most likely the asymmetry is rooted in the inward kinking of the N-terminal part of DHp α1 helix upon interaction with the ATP complexed CA domain (Fig. 7c ), which would be sterically incompatible with an analogous motion of α1 of the other subunit. This has been discussed and analyzed thoroughly by Bhate and coworkers 6 and corroborated by the recent structure and modelled dynamics of WalK 25 . Such asymmetric catalysis is not necessarily equivalent with half-of-sites modification and is, therefore, not at odds with our finding of complete modification at high ATP concentration (Fig. 5e ).
Disengagement of the CA domain after the first phosphorylation event could easily allow the other CA domain to approach the second histidine for modification (compare states 1 and 2 in Fig. 7a ).
Intriguingly, however, CpxA shows a hemi-phosphorylated crystal structure in the presence of ATP 17 , although the non-phosphorylated histidine seems perfectly poised to react with CA bound ATP in the observed canonical kinase competent arrangement. Based on our thermodynamic results on ShkA, we predict that CpxA behaves similarly, with the equilibrium of the reversible auto-phosphorylation reaction being on the side of the reactants (ATP, His). This would explain why the substrate and not the product complex was observed, since the products (ADP, P~His) would react back and ADP would stay in the active site assuming strong crystal lattice constraints.
Our analyses provide mechanistic and kinetic insight into how c-di-GMP competes with a proteinprotein interaction to activate an HHK, and how ADP affects the auto-phosphorylation reaction. For a full mechanistic understanding of HHKs, more investigations are required to decipher the kinetics of the phospho-transfer and auto-dephosphorylation steps and to unravel the physiological advantage of combining histidine kinase core and cognate receiver domain on one polypeptide.
Accession codes
Atomic coordinates and structure factors for the ShkA/AMPPNP and the ShkARec1/c-di-GMP complexes have been deposited in the Protein Data Bank under accession numbers 6QRJ and 6QRL, respectively. Sequence-specific backbone resonance assignment of the ShkARec2 domain has been submitted to the Biological Magnetic Resonance Data Bank under accession code 27882. Both Y338 and R324 interact with one of the phosphates. See also Supplementary Fig. 3a . Fig. 4 . Fig. 6c ) to the data with K1 = k1/k-1 = 0.13. Reactions with positive or negative cooperativity would yield the dashed curves (calculated with equilibrium constants for second phosphorylation event of 1.3 and 0.013, respectively) that do not fit the data. Inset: Representative oIEC chromatogram. 
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Methods
Cloning and protein expression for in vitro experiments
Vectors, primers, and recombinant proteins used in this study are listed in Supplementary Tables 1,   2, and 3 . In vitro experiments presented in this study were carried out using protein expressed from a pET-28a-shkA plasmid. The pET-28a-shkA vector carrying the gene coding for full-length, wild-type ShkA (Uniprot: Q9ABT2) was the same as used in the preceding study 9 . Most point mutants and wild-type variants were generated from this vector following the Q5 Site-Directed Mutagenesis Kit protocol (E0554, New England Biolabs) and primers 1-8 (Sup. Table 2 ). The results were verified by sequencing. Isoleucine point mutants used for the NMR study were cloned by standard mutagenesis using Phusion polymerase (Thermo Fisher Scientific) and primers 9-16 (Sup. 
ShkA crystallization
Protein solubilised in SEC buffer (see above) was crystallised using the sitting-drop vapor diffusion method. Sets of 3-drop MRC plates were prepared with a Gryphon robot (Art Robbins Instruments). 
Full-length
Nuclear Magnetic Resonance
All NMR spectra were recorded at 20 °C on a Bruker Avance-700 MHz spectrometer equipped with a cryogenically cooled triple-resonance probe. The following experiments were recorded with the 
Online ion exchange chromatography (oIEC) assay for acquisition of nucleotide turn-over progress curves
Nucleotide concentrations of an ongoing enzymatic reaction were determined in real-time by fast protein liquid chromatography (FPLC) using an ÄKTA Purifier instrument (GE Healthcare) equipped with a 1 mL Resource Q anion exchange (AEX) column and an A-905 autosampler.
With the newly developed oIEC method we acquired automatically quantitative enzyme progress curves by repetitive cycles of sample loading followed by salt gradient elution. Thereby, the reaction was started by addition of ATP substrate to the reaction mix in reaction buffer at t=0. This was followed by sequential aspiration of aliquots to the column in loading buffer (20 mM Tris-HCl, pH (2)
(4)
Thermodynamic modelling, ligand induced change in equilibrium (LICE)
For an enzyme in dynamic equilibrium between two states (active E, inactive C) and a ligand L that binds exclusively to the E-state (inset to Fig. 5B ), the following equations can be formulated The measured (apparent) rate constant is then given by PQ1,TUPV = • QP1 (13) (12) 
